MP (10 mg/kg) treatment showed significant (p < 0.05) inhibition in BLM-induced alterations in SOD, GSH, MDA, NO, and HP in the lung as compared to BLM controlled rats. This evidence concerns the gene SOD1 and Bloom syndrome.